Chemical inhibitors of Synaptotagmin XIII operate through various mechanisms to impede its role in neurotransmitter release. ω-Conotoxin GVIA, for instance, targets N-type voltage-gated calcium channels, crucial conduits for the calcium ions that Synaptotagmin XIII requires for triggering synaptic vesicle fusion. By inhibiting these channels, the conotoxin effectively reduces the calcium influx, thus impeding the protein's ability to facilitate neurotransmitter release. Similarly, ω-Agatoxin IVA and ω-Conotoxin MVIIC obstruct P/Q-type and a combination of N-type and P/Q-type calcium channels, respectively. These actions deprive Synaptotagmin XIII of the necessary calcium signals, thereby inhibiting its function in the release process. SNX-482 also contributes to this inhibition by targeting R-type voltage-gated calcium channels, further diminishing the calcium availability required for Synaptotagmin XIII's activity.
Toxins such as Botulinum toxin A and Tetanus toxin disrupt the SNARE complex, a molecular machine essential for vesicle fusion. Botulinum toxin A achieves this by cleaving SNAP-25, while Tetanus toxin cleaves synaptobrevin. Both actions prevent the proper assembly of the SNARE complex, thereby inhibiting Synaptotagmin XIII indirectly by disrupting the vesicle fusion process it mediates. Bafilomycin A1, on the other hand, inhibits the V-ATPase proton pump, which is vital for acidifying synaptic vesicles and enabling them to load neurotransmitters. This impedes the vesicle's ability to prepare for Synaptotagmin XIII-mediated release. ML-SI3, although a selective inhibitor of Synaptotagmin I, is presumed to reduce the activity of Synaptotagmin XIII as well, due to the functional similarities in calcium-dependent vesicle fusion. Furthermore, α-Latrotoxin triggers an influx of calcium ions, but it does so in a manner that depletes synaptic vesicles, indirectly inhibiting Synaptotagmin XIII by reducing the number of vesicles available for release. Lastly, Capsaicin and Clostridial toxins modulate presynaptic activity through distinct pathways but ultimately lead to a decrease in the activity that Synaptotagmin XIII relies upon to mediate vesicle fusion and neurotransmitter release. Capsaicin activates TRPV1 channels resulting in neuronal desensitization, while Clostridial toxins cleave VAMP, a vital component of the SNARE complex.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
ω-Agatoxin IVA | 145017-83-0 | sc-302015 | 100 µg | $463.00 | ||
ω-Agatoxin IVA selectively inhibits P/Q-type voltage-gated calcium channels. Synaptotagmin XIII's role in exocytosis is calcium-dependent, and by inhibiting these channels, the chemical can disrupt the calcium signaling necessary for Synaptotagmin XIII to facilitate neurotransmitter release. | ||||||
Bafilomycin A1 | 88899-55-2 | sc-201550 sc-201550A sc-201550B sc-201550C | 100 µg 1 mg 5 mg 10 mg | $98.00 $255.00 $765.00 $1457.00 | 280 | |
Bafilomycin A1 is a specific inhibitor of the V-ATPase proton pump necessary for acidifying synaptic vesicles. By inhibiting this pump, Bafilomycin A1 impedes the vesicle acidification and neurotransmitter loading, which are prerequisites for Synaptotagmin XIII-mediated neurotransmitter release. | ||||||
IC-87114 | 371242-69-2 | sc-364509 sc-364509A | 5 mg 50 mg | $140.00 $1060.00 | 1 | |
ML-SI3 is a selective inhibitor of the homologous Synaptotagmin I, which shares functional similarities with Synaptotagmin XIII. By inhibiting Synaptotagmin I, ML-SI3 can be presumed to reduce the activity of Synaptotagmin XIII as well due to the overlap in their mechanisms of action, particularly in calcium-dependent vesicle fusion and neurotransmitter release. | ||||||
Capsaicin | 404-86-4 | sc-3577 sc-3577C sc-3577D sc-3577A | 50 mg 250 mg 500 mg 1 g | $96.00 $160.00 $240.00 $405.00 | 26 | |
Capsaicin activates TRPV1 channels leading to neuronal desensitization and a decrease in neurotransmitter release. While not directly inhibiting Synaptotagmin XIII, the prolonged activation and subsequent desensitization can decrease the neuronal activity that Synaptotagmin XIII relies on to mediate vesicle release. | ||||||
Concanavalin A | 11028-71-0 | sc-203007 sc-203007A sc-203007B | 50 mg 250 mg 1 g | $119.00 $364.00 $947.00 | 17 | |
Clostridial toxins target and cleave VAMP, a vital component of the SNARE complex. By disrupting VAMP, these toxins inhibit the assembly of the SNARE complex, which is essential for the synaptic vesicle fusion process that Synaptotagmin XIII facilitates. | ||||||